U.S. stock market report [.N] 1058 ET 11Nov2008-Bristol-Myers stock drops after Avapro study results ----- Shares of Bristol-Myers Squibb Co (BMY.N) dropped 2 percent to $19.97 on ...
Today's Daily Dose brings you news about Arena's progress in phase II study of Etrasimod in ulcerative colitis; expanded FDA approval of Bristol-Myers' leukemia drug Sprycel; voluntarily delisting of Mylan's ordinary shares from the Tel Aviv …
NEW YORK, Nov 15 (Reuters) - Bristol-Myers Squibb Co (BMY.N) said on Sunday it plans to split off its 83 percent stake in Mead Johnson Nutrition Company MJN.N in a deal that lets Bristol shareholders exchange their shares for Mead …
Bristol-Myers Squibb will purchase all the outstanding capital stock of Flexus in an initial investment of $800 million …
Bristol-Myers investors are paid a 2.45% dividend. Credit Suisse puts a $68 price target on the stock. The consensus target is much lower at $63.41. Shares closed trading Thursday at $60.23. Another top company in the health care …
NEW YORK (CNN/Money) - Bristol-Myers Squibb is battered black and blue, and it just got punched in the gut again. But one industry watcher thinks the drugmaker can retrace its way back from a series of management missteps and effect …
The fall is all around us - this Sunday is the autumnal equinox and last Sunday spelled the end of Summers - yet stocks still stubbornly refuse to drop. S&P 500 Index (INDEXSP:.INX) shares advanced 1.98% and have now risen in nine of 10 …
Bristol-Myers Squibb (NYSE: BMY), in many ways, has led the immuno-oncology revolution with its game-changing checkpoint inhibitors Opdivo and Yervoy. However, the stock has lost a bit of its shine in the past year, thanks to …
Yahoo!1mon
Bristol-Myers Squibb Co. shares surged 3.2% in premarket trade Thursday after the company reported first-quarter profit and revenue beats. Earnings for the latest quarter rose to $1.57 billion, or 94 cents per share, from $1.20 billion, or 71 …